On February 29, 2024 Opyl announced an interim loss of $1.28m, up 106%.
Two weeks later, chairman Mark Ziirsen announced he was quitting.
Then, last Friday, Opyl revealed plans to divest the Opin division.
Given the dreadful interim result - and disclosure that Opin's cash burn is at least $70k a month - directors were obliged to take drastic action...either shutter the operation or find a buyer.
It seems that Dr Hugo Stephenson was the only one to put his hand up.
The more I think about the Opin dilemma, the more I understand the board decision to sell to Stephenson.
I don't want Opyl to announce a full year loss of $2m plus. And I don't want it to announce inevitable and on-going CRs.
No, the sooner it focusses on TrialKey, the sooner it can stem group losses and move towards profitability.
On February 29, 2024 Opyl announced an interim loss of $1.28m,...
Add OPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.218M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 798533 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 184163 | 2 |
View Market Depth
| Last trade - 11.35am 02/05/2024 (20 minute delay) ? |
| OPL (ASX) Chart |
Day chart unavailable